Newroom
SUL-compounds: first-in-class mitochondria-targeted medicines as potential treatment for cardiac and vascular pathologies
There is another medical need application of the SUL-compound group with SUL-150, a compound closely related to SUL-238. Recently, a new scientific paper has been published in The International Journal of Molecular Sciences about the potential of...
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
SUL-238, a first-in-class medicine, protects from ageing
We are happy to share great news! SUL-238 is currently in Phase I clinical trials in collaboration with our Turkish partner GEN Ilac. It is the first drug reported that leads to persisting improvement of vascular aging. This work has recently been...
SUL-238 featured in Nature Medicine
We are excited to announce that our lead drug candidate SUL-238 has been featured in the prestigious journal Nature Medicine. The article highlights hibernation as a source of inspiration for drug development, which also forms the basis for our...
Waarom hebben mensen geen winterslaap?
https://open.spotify.com/episode/7sC62GDjmc0g2oQFu4XZo0
Wintersleep as medicine?
Wintersleep or hibernation is used by some animals to survive harsh environmental conditions, but not all animals can hibernate. Interestingly, hibernators possess protective mechanisms that allows them to withstand or repair cell and organ damage...